Physical activity cuts mortality in colorectal cancer survivors

January 23, 2013
Physical activity cuts mortality in colorectal cancer survivors
For patients with invasive, non-metastatic colorectal cancer, increased recreational physical activity is associated with reduced all-cause mortality, while prolonged sedentary time correlates with increased all-cause mortality, according to a study published online Jan. 22 in the Journal of Clinical Oncology.

(HealthDay)—For patients with invasive, non-metastatic colorectal cancer, increased recreational physical activity is associated with reduced all-cause mortality, while prolonged sedentary time correlates with increased all-cause mortality, according to a study published online Jan. 22 in the Journal of Clinical Oncology.

Peter T. Campbell, Ph.D., from the National Home Office in Atlanta, and colleagues examined the correlation of pre-diagnosis and post-diagnosis recreational physical activity and sedentary leisure time with mortality among 2,293 adults diagnosed with invasive, non- from a cohort of adults without colorectal cancer at baseline.

During a maximum follow-up of 16.1 years after colorectal , the researchers found that 846 patients died—379 from colorectal cancer. Significantly lower all-cause mortality was seen for those who engaged in 8.75 or more metabolic equivalent (MET) hours per week of recreational activity versus less than 3.5 MET hours (relative risks for pre-diagnosis and post-diagnosis physical activity, 0.72 and 0.58, respectively). Higher all-cause mortality was seen for those who spent six or more hours per day of leisure time sitting compared with fewer than three hours per day (relative risks for pre-diagnosis and post-diagnosis sitting time, 1.36 and 1.27, respectively).

"In conclusion, this study supports public health recommendations for recreational physical activity and the avoidance of sedentary time among colorectal cancer survivors," the authors write.

Explore further: Statin use at cancer diagnosis linked to lower mortality

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Statin use at cancer diagnosis linked to lower mortality

November 8, 2012
(HealthDay)—For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Journal of Medicine.

Study finds colorectal cancer mortality dropping slower in African Americans

December 22, 2011
A new study finds that while colorectal cancer mortality rates dropped in the most recent two decades for every stage in both African Americans and whites, the decreases were smaller for African Americans, particularly for ...

Adherence to cancer surveillance guidelines varies

March 30, 2012
(HealthDay) -- Insured breast cancer survivors have high rates of guideline-recommended recurrence testing and non-recommended metastatic testing, while only about half of colorectal cancer survivors undergo recommended surveillance ...

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.